PL3225233T3 - Roztwór chlorku sodu do odtwarzania leku - Google Patents

Roztwór chlorku sodu do odtwarzania leku

Info

Publication number: PL3225233T3
Authority: PL; Poland
Prior art keywords: sodium chloride; chloride solution; drug reconstitution; reconstitution; drug
Prior art date: 2005-11-01

Application number

PL17166616T

Other languages

English (en)

Inventor

Chandra A. Webb

Julie Zerfas

Original Assignee

Wyeth Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-01

Filing date

2006-10-27

Publication date

2019-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37801586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3225233(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-27 Application filed by Wyeth Llc filed Critical Wyeth Llc

2019-12-31 Publication of PL3225233T3 publication Critical patent/PL3225233T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL17166616T 2005-11-01 2006-10-27 Roztwór chlorku sodu do odtwarzania leku PL3225233T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US73222105P	2005-11-01	2005-11-01
PCT/US2006/042258 WO2007053533A2 (en)	2005-11-01	2006-10-27	Sodium chloride solution for drug reconstitution or dilution
EP17166616.7A EP3225233B1 (en)	2005-11-01	2006-10-27	Sodium chloride solution for drug reconstitution
EP06827036.2A EP1942868B2 (en)	2005-11-01	2006-10-27	Sodium chloride solution for drug reconstitution or dilution

Publications (1)

Publication Number	Publication Date
PL3225233T3 true PL3225233T3 (pl)	2019-12-31

Family

ID=37801586

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL06827036.2T PL1942868T5 (pl)	2005-11-01	2006-10-27	Roztwór chlorku sodu do odtwarzania lub rozcieńczania leku
PL17166616T PL3225233T3 (pl)	2005-11-01	2006-10-27	Roztwór chlorku sodu do odtwarzania leku

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL06827036.2T PL1942868T5 (pl)	2005-11-01	2006-10-27	Roztwór chlorku sodu do odtwarzania lub rozcieńczania leku

Country Status (31)

Country	Link
US (4)	US20070135343A1 (pl)
EP (3)	EP3593790A1 (pl)
JP (1)	JP5555425B2 (pl)
KR (2)	KR20110128957A (pl)
CN (1)	CN101351190B (pl)
AR (2)	AR056748A1 (pl)
AU (1)	AU2006308921C1 (pl)
BR (1)	BRPI0618133A2 (pl)
CA (1)	CA2626531C (pl)
CR (1)	CR9958A (pl)
DK (2)	DK3225233T3 (pl)
EC (1)	ECSP088485A (pl)
ES (2)	ES2749574T3 (pl)
FI (1)	FI1942868T4 (pl)
FR (1)	FR20C1005I1 (pl)
GT (1)	GT200800037A (pl)
HK (1)	HK1245090B (pl)
HU (4)	HUE045421T2 (pl)
IL (1)	IL190843A (pl)
LU (1)	LUC00035I2 (pl)
MY (1)	MY184364A (pl)
NO (1)	NO347263B1 (pl)
NZ (1)	NZ567685A (pl)
PE (3)	PE20151284A1 (pl)
PL (2)	PL1942868T5 (pl)
PT (2)	PT3225233T (pl)
RU (1)	RU2432157C2 (pl)
SI (2)	SI1942868T2 (pl)
TW (1)	TWI480063B (pl)
UA (1)	UA97234C2 (pl)
WO (1)	WO2007053533A2 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL1942868T5 (pl)	2005-11-01	2023-12-27	Wyeth Llc	Roztwór chlorku sodu do odtwarzania lub rozcieńczania leku
US7767206B2 (en)	2006-10-02	2010-08-03	Amgen Inc.	Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
US8431011B2 (en) *	2008-01-31	2013-04-30	Abbott Diabetes Care Inc.	Method for automatically and rapidly distinguishing between control and sample solutions in a biosensor strip
EP2501367B1 (en) *	2009-11-17	2015-01-21	Ipsen Pharma S.A.S.	Formulation for HGH and RHIGF-1 combination
US10634741B2 (en)	2009-12-04	2020-04-28	Endomagnetics Ltd.	Magnetic probe apparatus
US9427186B2 (en)	2009-12-04	2016-08-30	Endomagnetics Ltd.	Magnetic probe apparatus
PH12012501364A1 (en)	2010-01-15	2012-10-22	Amgen K A Inc	Antibody formulation and therapeutic regimens
NZ602685A (en)	2010-03-01	2014-10-31	Cytodyn Inc	Concentrated protein formulations and uses thereof
PL3552619T3 (pl)	2010-07-09	2025-12-01	Bioverativ Therapeutics Inc.	Polipeptydy czynnika ix i sposoby ich zastosowania
HK1213521A1 (zh) *	2012-09-25	2016-07-08	Bioverativ Therapeutics Inc.	Fix多肽的應用
ES2803506T3 (es)	2013-03-11	2021-01-27	Endomagnetics Ltd	Soluciones hipoosmóticas para la detección de ganglios linfáticos
US9234877B2 (en)	2013-03-13	2016-01-12	Endomagnetics Ltd.	Magnetic detector
US9239314B2 (en)	2013-03-13	2016-01-19	Endomagnetics Ltd.	Magnetic detector
WO2014144549A1 (en) *	2013-03-15	2014-09-18	Biogen Idec Ma Inc.	Factor ix polypeptide formulations
FR3005420B1 (fr)	2013-05-07	2015-09-18	Erytech Pharma	Procede de stabilisation de suspensions d'erythrocytes encapsulant un principe actif, suspensions obtenues.
AU2015236340B2 (en) *	2014-03-24	2020-02-06	Bioverativ Therapeutics Inc.	Lyophilized factor IX formulations
US9351945B1 (en)	2015-02-27	2016-05-31	John Daniel Dobak, III	Reduction of adipose tissue
GB2536703B (en) *	2015-03-27	2020-12-02	Ge Healthcare Bio Sciences Ab	Method for baseline correction in a chromatogram
EP3081942A1 (en) *	2015-04-17	2016-10-19	Roche Diagniostics GmbH	Pressure transmission liquid for cellular analyzer, cellular analyzer and method for analyzing a liquid cellular sample
MX390935B (es)	2015-06-04	2025-03-21	Endomagnetics Ltd	Materiales marcadores y formas para la localización de marcadores magnéticos (mml).
US10124021B2 (en) *	2016-12-23	2018-11-13	Andrew L. Gostine	Intravenous fluid
JP7110360B2 (ja)	2017-10-09	2022-08-01	テルモビーシーティーバイオテクノロジーズ，エルエルシー	凍結乾燥方法
CN113597532B (zh)	2019-03-14	2023-02-17	泰尔茂比司特生物技术有限公司	冻干容器填充固定装置、系统及使用方法
US12036187B2 (en) *	2019-05-01	2024-07-16	Southwest Research Institute	Compositions of dimethyl trisulfide (DMTS) as a cyanide antidote
WO2021108051A2 (en) *	2019-10-25	2021-06-03	Cmc Pharmaceuticals, Inc.	Atropine-scopolamine with enhanced stability
IL272145A (en) *	2020-01-20	2021-07-29	Stem Cell Medicine Ltd	Cosmetic compositions with protein concentrate from conditioned medium of adipose-derived stem cells
JP2023538831A (ja) *	2020-08-03	2023-09-12	トランスルミナル、システムズ、リミテッド、ライアビリティー、カンパニー	病理組織の経動脈浸透圧塞栓形成のためのデバイスおよび方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3717708A (en) *	1968-10-24	1973-02-20	Cutter Lab	Blood coagulation complex
US4364861A (en)	1980-05-27	1982-12-21	Cutter Laboratories, Inc.	Blood-coagulation-promoting products and methods of preparing them
US6372716B1 (en)	1994-04-26	2002-04-16	Genetics Institute, Inc.	Formulations for factor IX
DK1820516T3 (da)	1999-02-22	2013-10-28	Univ Connecticut	Nye albuminfrie faktor VIII-præparater
US20010031721A1 (en) *	1999-05-05	2001-10-18	Chandra Webb	Highly concentrated, lyophilized, and liquid factor IX formulations
AU2002213441B2 (en) *	2000-10-12	2006-10-26	Genentech, Inc.	Reduced-viscosity concentrated protein formulations
CN1917861B (zh)	2003-12-19	2012-03-21	诺和诺德医疗保健公司	因子vii多肽的稳定化固体组合物
BRPI0509117A (pt)	2004-03-04	2007-08-28	Wyeth Corp	método de liofilização para melhorar a cristalização de excipientes
PL1942868T5 (pl)	2005-11-01	2023-12-27	Wyeth Llc	Roztwór chlorku sodu do odtwarzania lub rozcieńczania leku

2006
- 2006-10-27 PL PL06827036.2T patent/PL1942868T5/pl unknown
- 2006-10-27 CA CA2626531A patent/CA2626531C/en active Active
- 2006-10-27 DK DK17166616.7T patent/DK3225233T3/da active
- 2006-10-27 HU HUE17166616A patent/HUE045421T2/hu unknown
- 2006-10-27 PE PE2015001729A patent/PE20151284A1/es not_active Application Discontinuation
- 2006-10-27 ES ES17166616T patent/ES2749574T3/es active Active
- 2006-10-27 NO NO20082180A patent/NO347263B1/no unknown
- 2006-10-27 PE PE2011000653A patent/PE20110803A1/es not_active Application Discontinuation
- 2006-10-27 EP EP19189599.4A patent/EP3593790A1/en not_active Withdrawn
- 2006-10-27 US US11/589,002 patent/US20070135343A1/en not_active Abandoned
- 2006-10-27 HU HUE06827036A patent/HUE033949T2/hu unknown
- 2006-10-27 PL PL17166616T patent/PL3225233T3/pl unknown
- 2006-10-27 RU RU2008119514/15A patent/RU2432157C2/ru active
- 2006-10-27 TW TW095139724A patent/TWI480063B/zh active
- 2006-10-27 KR KR1020117027131A patent/KR20110128957A/ko not_active Withdrawn
- 2006-10-27 WO PCT/US2006/042258 patent/WO2007053533A2/en not_active Ceased
- 2006-10-27 EP EP06827036.2A patent/EP1942868B2/en active Active
- 2006-10-27 PT PT171666167T patent/PT3225233T/pt unknown
- 2006-10-27 AU AU2006308921A patent/AU2006308921C1/en active Active
- 2006-10-27 DK DK06827036.2T patent/DK1942868T5/da active
- 2006-10-27 CN CN2006800400807A patent/CN101351190B/zh active Active
- 2006-10-27 PT PT68270362T patent/PT1942868T/pt unknown
- 2006-10-27 EP EP17166616.7A patent/EP3225233B1/en not_active Revoked
- 2006-10-27 SI SI200632172T patent/SI1942868T2/sl unknown
- 2006-10-27 KR KR1020087013252A patent/KR101126670B1/ko active Active
- 2006-10-27 ES ES06827036T patent/ES2627684T5/es active Active
- 2006-10-27 NZ NZ567685A patent/NZ567685A/en unknown
- 2006-10-27 PE PE2006001318A patent/PE20070714A1/es not_active Application Discontinuation
- 2006-10-27 MY MYPI20081347A patent/MY184364A/en unknown
- 2006-10-27 UA UAA200807432A patent/UA97234C2/ru unknown
- 2006-10-27 BR BRPI0618133-3A patent/BRPI0618133A2/pt not_active Application Discontinuation
- 2006-10-27 JP JP2008538945A patent/JP5555425B2/ja active Active
- 2006-10-27 SI SI200632348T patent/SI3225233T1/sl unknown
- 2006-10-31 AR ARP060104769A patent/AR056748A1/es not_active Application Discontinuation
2008
- 2008-04-14 IL IL190843A patent/IL190843A/en active IP Right Grant
- 2008-04-17 GT GT200800037A patent/GT200800037A/es unknown
- 2008-05-07 CR CR9958A patent/CR9958A/es not_active Application Discontinuation
- 2008-05-30 EC EC2008008485A patent/ECSP088485A/es unknown
2016
- 2016-10-07 US US15/288,860 patent/US20170021022A1/en not_active Abandoned
2017
- 2017-09-25 LU LU00035C patent/LUC00035I2/fr unknown
- 2017-09-27 HU HUS1700035C patent/HUS1700035I1/hu unknown
2018
- 2018-04-04 HK HK18104477.4A patent/HK1245090B/en unknown
- 2018-07-06 AR ARP180101902 patent/AR112443A2/es not_active Application Discontinuation
2019
- 2019-12-20 US US16/723,563 patent/US20200138952A1/en not_active Abandoned
2020
- 2020-01-31 HU HUS2000003C patent/HUS2000003I1/hu unknown
- 2020-02-10 FR FR20C1005C patent/FR20C1005I1/fr active Active
- 2020-07-14 US US16/946,998 patent/US20200338199A1/en not_active Abandoned
2023
- 2023-03-17 FI FIEP06827036.2T patent/FI1942868T4/fi active

Also Published As

Publication number	Publication date
DK1942868T4 (da)	2023-11-06
UA97234C2 (ru)	2012-01-25
TWI480063B (zh)	2015-04-11
BRPI0618133A2 (pt)	2011-08-16
IL190843A (en)	2013-08-29
ECSP088485A (es)	2008-06-30
TW200803915A (en)	2008-01-16
AR112443A2 (es)	2019-10-30
US20070135343A1 (en)	2007-06-14
DK1942868T3 (en)	2017-06-26
SI1942868T1 (sl)	2017-07-31
PL1942868T5 (pl)	2023-12-27
EP3225233A1 (en)	2017-10-04
HUE033949T2 (hu)	2018-01-29
US20200338199A1 (en)	2020-10-29
PT1942868T (pt)	2017-06-16
IL190843A0 (en)	2008-11-03
LUC00035I2 (pl)	2017-12-01
CN101351190A (zh)	2009-01-21
KR101126670B1 (ko)	2012-04-23
PL1942868T3 (pl)	2017-09-29
JP2009513705A (ja)	2009-04-02
SI1942868T2 (sl)	2023-12-29
CN101351190B (zh)	2013-01-02
EP1942868B2 (en)	2023-10-04
ES2749574T3 (es)	2020-03-23
PE20151284A1 (es)	2015-10-05
FI1942868T4 (fi)	2023-10-12
WO2007053533A8 (en)	2008-07-24
US20170021022A1 (en)	2017-01-26
RU2008119514A (ru)	2009-12-10
PT3225233T (pt)	2019-10-24
HUS1700035I1 (hu)	2017-11-28
KR20110128957A (ko)	2011-11-30
AR056748A1 (es)	2007-10-24
ES2627684T3 (es)	2017-07-31
PE20070714A1 (es)	2007-07-20
EP3593790A1 (en)	2020-01-15
FR20C1005I1 (fr)	2020-03-20
LUC00035I1 (pl)	2017-09-28
RU2432157C2 (ru)	2011-10-27
CA2626531A1 (en)	2007-05-10
HUS2000003I1 (hu)	2020-02-28
WO2007053533A2 (en)	2007-05-10
MY184364A (en)	2021-04-01
AU2006308921A1 (en)	2007-05-10
HUE045421T2 (hu)	2019-12-30
CR9958A (es)	2008-07-29
KR20080065689A (ko)	2008-07-14
NZ567685A (en)	2011-07-29
US20200138952A1 (en)	2020-05-07
AU2006308921C1 (en)	2013-01-24
CA2626531C (en)	2011-11-29
JP5555425B2 (ja)	2014-07-23
DK3225233T3 (da)	2019-10-14
AU2006308921B2 (en)	2012-07-19
SI3225233T1 (sl)	2019-10-30
EP1942868A2 (en)	2008-07-16
NO20082180L (no)	2008-07-04
ES2627684T5 (es)	2024-04-29
HK1245090B (en)	2020-04-09
EP1942868B1 (en)	2017-04-19
EP3225233B1 (en)	2019-08-14
NO347263B1 (no)	2023-08-14
PE20110803A1 (es)	2011-11-07
DK1942868T5 (da)	2024-01-08
WO2007053533A3 (en)	2007-12-06
NO20082180A (no)	2008-07-04
GT200800037A (es)	2008-10-01

Publication	Publication Date	Title
HUS2000003I1 (hu)	2020-02-28	Nátrium klorid oldat gyógyszer újraoldására
IL191907A0 (en)	2008-12-29	Azepinoindole derivatives as pharmaceutical agents
GB0501999D0 (en)	2005-03-09	Pharmaceutical compounds
GB0520657D0 (en)	2005-11-16	Pharmaceutical compounds
ZA200801275B (en)	2008-12-31	Pharmaceutical preparation containing meloxicam
GB0520656D0 (en)	2005-11-16	Pharmaceutical compounds
IL188438A0 (en)	2008-11-03	New pharmaceutical compounds
EP1776112A4 (en)	2009-11-25	HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS
EP1852117A4 (en)	2010-10-27	PHARMACEUTICAL AGENT COMPRISING SOLIFENACIN
GB0512643D0 (en)	2005-07-27	Pharmaceutical compounds
ZA200800515B (en)	2008-12-31	New Salt I
EP1871344A4 (en)	2012-05-02	INHIBITABLE MEDICINAL PRODUCT
ZA200705612B (en)	2009-09-30	Pharmaceutical compounds
GB0501475D0 (en)	2005-03-02	Pharmaceutical compounds
GB0515315D0 (en)	2005-08-31	Pharmaceutical agents
GB0514530D0 (en)	2005-08-24	Pharmaceutical agent
GB0512642D0 (en)	2005-07-27	Pharmaceutical compounds
GB0510252D0 (en)	2005-06-29	Pharmaceutical compounds
GB0501310D0 (en)	2005-03-02	Pharmaceutical compounds
GB0526607D0 (en)	2006-02-08	Pharmaceutical compounds
GB0501729D0 (en)	2005-03-02	Pharmaceutical compounds
GB0516167D0 (en)	2005-09-14	Pharmaceutical compounds
GB0501998D0 (en)	2005-03-09	Pharmaceutical compounds
GB0516790D0 (en)	2005-09-21	Pharmaceutical compounds
GB0512654D0 (en)	2005-07-27	Pharmaceutical compounds